Suppr超能文献

[肝胆系统疾病患者中的幽门螺杆菌]

[Helicobacter pylori in patients with disorders of hepatobiliary system].

作者信息

Isaeva G Sh, Abuzarova E R, Valeeva Iu V, Pozdeev O K, Murav'eva E V

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr(2):96-101.

Abstract

AIM

Detection of H. pylori in gastric mucosa, bile-excreting ducts, livertissue, and bile of patients with different disorders hepatobiliary system (HBS).

MATERIALS AND METHODS

Seventy-six patients (52 females and 24 males) with following diagnoses: chronic noncalculous cholecystitis (25 patients), gallstone disease (28), liver cirrhosis (12), ischemic heart disease (control group, n = 11), admitted to hospitals in Kazan and Zelenodolsk (Republic of Tatarstan), were examined. Mean age of the patients was 56.5 years. Samples of bile as well as tissues of liver, bile ducts and gastric mucosa were used as materials for tests. Polymerase chain reaction and culture method were used for H. pylori detection.

RESULTS

Analysis of obtained results showed association of clinical diagnosis and presence of H. pylori DNA in bile ducts mucosal epithelium. H. pylori was significantly more frequently detected in epithelium of bile ducts mucosa (66.7 +/- 13.6%) and bile(56 +/- 9.9%) than in liver tissue (33.3 +/- 13.6%) (p < 0.05). Rate of H. pylori detection in gastric mucosa (83.3 +/- 10.8% in patients with liver cirrhosis) correlated with its detection rate in bile ducts mucosa (66.7 +/- 13.6%). In the control group of 11 patients with ischemic heart disease H. pylori was not detected. In 16 samples of liver, bile ducts, and gastric tissues CagA-negative phenotype was observed.

CONCLUSION

Presence of H. pylori in liver, bile ducts and bile could point to possible role of its microorganism in pathogenesis of hepatobiliary diseases.

摘要

目的

检测不同肝胆系统疾病(HBS)患者胃黏膜、胆管、肝组织及胆汁中的幽门螺杆菌。

材料与方法

对76例患者(52例女性,24例男性)进行了检查,这些患者的诊断如下:慢性非结石性胆囊炎(25例)、胆结石病(28例)、肝硬化(12例)、缺血性心脏病(对照组,n = 11例),他们均入住喀山和泽列诺多尔斯克(鞑靼斯坦共和国)的医院。患者的平均年龄为56.5岁。胆汁样本以及肝、胆管和胃黏膜组织用作检测材料。采用聚合酶链反应和培养法检测幽门螺杆菌。

结果

对所得结果的分析表明,临床诊断与胆管黏膜上皮中幽门螺杆菌DNA的存在有关。在胆管黏膜上皮(66.7±13.6%)和胆汁(56±9.9%)中检测到幽门螺杆菌的频率明显高于肝组织(33.3±13.6%)(p < 0.05)。胃黏膜中幽门螺杆菌的检测率(肝硬化患者中为83.3±10.8%)与其在胆管黏膜中的检测率(66.7±13.6%)相关。在11例缺血性心脏病对照组患者中未检测到幽门螺杆菌。在16份肝、胆管和胃组织样本中观察到CagA阴性表型。

结论

肝、胆管和胆汁中存在幽门螺杆菌可能表明该微生物在肝胆疾病发病机制中可能发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验